Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: Olorofim in Early Coccidioidal Meningitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of olorofim for early coccidioidal meningitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olorofim (olorofim)

Snippet

Sponsor: Fariba Donovan | Conditions: Coccidioidal Meningitis | Phase 2 | Status: NOT_YET_RECRUITING